Clinical Trial Update: A Research Study in Chinese People With Allergy to House Dust Mites, Using an Environmental Exposure Chamber [Phase 3]

View source ↗

Summary

Phase 3 clinical trial in Chinese participants with house dust mite allergy using an environmental exposure chamber has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinoconjunctivitis

Drugs mentioned

• ALK-Abelló A/S

Snippet

Sponsor: ALK-Abelló A/S | Conditions: Allergic Rhinoconjunctivitis | Phase 3 | Status: TERMINATED